Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Propranolol was first approved for angina pectoris treatment in Japan on August 18, 1966, and carvedilol was first approved for angina pectoris, essential hypertension, and renal hypertension treatment in Japan on January 19, 1993
Biggest exits drive ecosystem confidence Mega rounds + pharma acquisitions of biotech send the strongest external signal that obesity remains a top-priority therapeutic area
We strive to build an inclusive culture where differences are celebrated and leveraged to inform better design and business decisions
In this sense, they may be thought of as disease-modifying agents instead of glucose-lowering therapy
Blood 102:860a, 2003
US$ 24.42
US$ 24.88
US$ 22.44
US$ 24.09
